These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 8971094)

  • 1. Potential role of an endothelium-specific growth factor, hepatocyte growth factor, on endothelial damage in diabetes.
    Morishita R; Nakamura S; Nakamura Y; Aoki M; Moriguchi A; Kida I; Yo Y; Matsumoto K; Nakamura T; Higaki J; Ogihara T
    Diabetes; 1997 Jan; 46(1):138-42. PubMed ID: 8971094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of hepatocyte growth factor in endothelial regulation: prevention of high D-glucose-induced endothelial cell death by prostaglandins and phosphodiesterase type 3 inhibitor.
    Morishita R; Higaki J; Hayashi SI; Yo Y; Aoki M; Nakamura S; Moriguchi A; Matsushita H; Matsumoto K; Nakamura T; Ogihara T
    Diabetologia; 1997 Sep; 40(9):1053-61. PubMed ID: 9300242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative regulation of local hepatocyte growth factor expression by angiotensin II and transforming growth factor-beta in blood vessels: potential role of HGF in cardiovascular disease.
    Nakano N; Morishita R; Moriguchi A; Nakamura Y; Hayashi SI; Aoki M; Kida I; Matsumoto K; Nakamura T; Higaki J; Ogihara T
    Hypertension; 1998 Sep; 32(3):444-51. PubMed ID: 9740609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocyte growth factor is a novel member of the endothelium-specific growth factors: additive stimulatory effect of hepatocyte growth factor with basic fibroblast growth factor but not with vascular endothelial growth factor.
    Nakamura Y; Morishita R; Higaki J; Kida I; Aoki M; Moriguchi A; Yamada K; Hayashi S; Yo Y; Nakano H; Matsumoto K; Nakamura T; Ogihara T
    J Hypertens; 1996 Sep; 14(9):1067-72. PubMed ID: 8986905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autocrine-paracrine effects of overexpression of hepatocyte growth factor gene on growth of endothelial cells.
    Hayashi S; Morishita R; Higaki J; Aoki M; Moriguchi A; Kida I; Yoshiki S; Matsumoto K; Nakamura T; Kaneda Y; Ogihara T
    Biochem Biophys Res Commun; 1996 Mar; 220(3):539-45. PubMed ID: 8607801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Actions of hepatocyte growth factor as a local modulator in the kidney: potential role in pathogenesis of renal disease.
    Yo Y; Morishita R; Yamamoto K; Tomita N; Kida I; Hayashi S; Moriguchi A; Kato S; Matsumoto K; Nakamura T; Higaki J; Ogihara T
    Kidney Int; 1998 Jan; 53(1):50-8. PubMed ID: 9452999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocyte growth factor prevents endothelial cell death through inhibition of bax translocation from cytosol to mitochondrial membrane.
    Nakagami H; Morishita R; Yamamoto K; Taniyama Y; Aoki M; Yamasaki K; Matsumoto K; Nakamura T; Kaneda Y; Ogihara T
    Diabetes; 2002 Aug; 51(8):2604-11. PubMed ID: 12145177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of local hepatocyte growth factor system in vascular tissues.
    Nakamura Y; Morishita R; Higaki J; Kida I; Aoki M; Moriguchi A; Yamada K; Hayashi S; Yo Y; Matsumoto K
    Biochem Biophys Res Commun; 1995 Oct; 215(2):483-8. PubMed ID: 7487981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential role of hepatocyte growth factor in the maintenance of renal structure: anti-apoptotic action of HGF on epithelial cells.
    Yo Y; Morishita R; Nakamura S; Tomita N; Yamamoto K; Moriguchi A; Matsumoto K; Nakamura T; Higaki J; Ogihara T
    Kidney Int; 1998 Oct; 54(4):1128-38. PubMed ID: 9767528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A vascular modulator, hepatocyte growth factor, is associated with systolic pressure.
    Nakamura Y; Morishita R; Nakamura S; Aoki M; Moriguchi A; Matsumoto K; Nakamura T; Higaki J; Ogihara T
    Hypertension; 1996 Sep; 28(3):409-13. PubMed ID: 8794825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential role of a novel vascular modulator, hepatocyte growth factor (HGF), in cardiovascular disease: characterization and regulation of local HGF system.
    Morishita R; Aoki M; Nakamura S; Matsushita H; Tomita N; Hayashi S; Moriguchi A; Matsumoto K; Nakamura T; Higaki J; Ogihara T
    J Atheroscler Thromb; 1997; 4(1):12-9. PubMed ID: 9583349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conditioned medium from HepG2 cells transfected with human apolipoprotein(a) gene stimulates growth of human vascular smooth muscle cells: effects of overexpression of human apolipoprotein(a) gene.
    Morishita R; Yamada S; Higaki J; Tomita N; Kida I; Aoki M; Moriguchi A; Hayashi S; Sakurabayashi I; Kaneda Y; Ogihara T
    Hypertension; 1998 Aug; 32(2):215-22. PubMed ID: 9719045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-apoptotic action of hepatocyte growth factor through mitogen-activated protein kinase on human aortic endothelial cells.
    Nakagami H; Morishita R; Yamamoto K; Taniyama Y; Aoki M; Kim S; Matsumoto K; Nakamura T; Higaki J; Ogihara T
    J Hypertens; 2000 Oct; 18(10):1411-20. PubMed ID: 11057428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increase in peripheral blood flow by intravenous administration of prostaglandin E1 in patients with peripheral arterial disease, accompanied by up-regulation of hepatocyte growth factor.
    Makino H; Aoki M; Hashiya N; Yamasaki K; Hiraoka K; Shimizu H; Azuma J; Kurinami H; Ogihara T; Morishita R
    Hypertens Res; 2004 Feb; 27(2):85-91. PubMed ID: 15005271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential role of hepatocyte growth factor, a novel angiogenic growth factor, in peripheral arterial disease: downregulation of HGF in response to hypoxia in vascular cells.
    Hayashi S; Morishita R; Nakamura S; Yamamoto K; Moriguchi A; Nagano T; Taiji M; Noguchi H; Matsumoto K; Nakamura T; Higaki J; Ogihara T
    Circulation; 1999 Nov; 100(19 Suppl):II301-8. PubMed ID: 10567320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of endothelial dysfunction by angiotensin II blockade accompanied by induction of vascular hepatocyte growth factor system in diabetic spontaneously hypertensive rats.
    Matsumoto K; Morishita R; Tomita N; Moriguchi A; Komai N; Aoki M; Matsumoto K; Nakamura T; Higaki J; Ogihara T
    Heart Vessels; 2003 Mar; 18(1):18-25. PubMed ID: 12644877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat diabetic hind limb ischemia model: molecular mechanisms of delayed angiogenesis in diabetes.
    Taniyama Y; Morishita R; Hiraoka K; Aoki M; Nakagami H; Yamasaki K; Matsumoto K; Nakamura T; Kaneda Y; Ogihara T
    Circulation; 2001 Nov; 104(19):2344-50. PubMed ID: 11696476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired endothelial dysfunction in diabetes mellitus rats was restored by oral administration of prostaglandin I2 analogue.
    Matsumoto K; Morishita R; Tomita N; Moriguchi A; Yamasaki K; Aoki M; Matsumoto K; Nakamura T; Higaki J; Ogihara T
    J Endocrinol; 2002 Oct; 175(1):217-23. PubMed ID: 12379506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kringle 1-4 of hepatocyte growth factor inhibits proliferation and migration of human microvascular endothelial cells.
    Kuba K; Matsumoto K; Ohnishi K; Shiratsuchi T; Tanaka M; Nakamura T
    Biochem Biophys Res Commun; 2000 Dec; 279(3):846-52. PubMed ID: 11162438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial heparan sulfate is necessary but not sufficient for control of vascular smooth muscle cell growth.
    Ettenson DS; Koo EW; Januzzi JL; Edelman ER
    J Cell Physiol; 2000 Jul; 184(1):93-100. PubMed ID: 10825238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.